{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:01:22Z","timestamp":1785902482415,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijantimicag.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,22]],"date-time":"2018-07-22T13:45:16Z","timestamp":1532267116000},"page":"688-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Assessing the in vitro activity of ceftazidime\/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope"],"prefix":"10.1016","volume":"52","author":[{"given":"Lindsay M.","family":"Avery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijantimicag.2018.07.011_bib0001","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/cid\/cix387","article-title":"Application of \u201cprecision medicine\u201d through the molecular characterization of extensively drug-resistant Klebsiella pneumoniae in a multivisceral transplant patient","volume":"65","author":"Rosa","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijantimicag.2018.07.011_bib0002","doi-asserted-by":"crossref","first-page":"e01008","DOI":"10.1128\/AAC.01008-17","article-title":"Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa","volume":"61","author":"Davido","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2018.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jac\/dkx496","article-title":"Clinical outcomes after combination treatment with ceftazidime\/avibactam and aztreonam for NDM-1\/OXA-48\/CTX-M-15-producing Klebsiella pneumoniae infection","volume":"73","author":"Shaw","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2018.07.011_bib0004","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/cid\/cit578","article-title":"Better tests, better care: improved diagnostics for infectious diseases","volume":"57","author":"Caliendo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0005","article-title":"Can ceftazidime-avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae?","volume":"71","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2018.07.011_bib0006","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diagmicrobio.2017.05.009","article-title":"Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-\u03b2-lactamase-producing gram-negative pathogens","volume":"88","author":"Wenzler","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2018.07.011_bib0007","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/jac\/dkx393","article-title":"Ceftazidime\/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae","volume":"73","author":"Jayol","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2018.07.011_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01856-17","article-title":"Antimicrobial activities of aztreonam-avibactam and comparator agents against contemporary (2016) clinical Enterobacteriaceae isolates","volume":"62","author":"Sader","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00486-17","article-title":"In vitro discordance with in vivo activity: humanized exposures of ceftazidime-avibactam, aztreonam, and tigecycline alone and in combination against New Delhi metallo-\u03b2-lactamase-producing Klebsiella pneumoniae in a murine lung infection model","volume":"61","author":"Monogue","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2018.07.011_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.diagmicrobio.2013.07.006","article-title":"Comparison of 3 Etest\u24c7 methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species","volume":"77","author":"Pankey","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0011","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"Hall","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0012","unstructured":"Liofilchem. MIC Test Strip Technical Sheet Synergy Testing-MTS31-Rev.5, http:\/\/www.liofilchem.net\/login.area.mic\/technical_sheets\/MTS31.pdf [accessed 20.01.18]."},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0013","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijantimicag.2014.10.020","article-title":"Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution","volume":"45","author":"Wind","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/00365548.2012.732240","article-title":"Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates","volume":"45","author":"Church","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.07.011_bib0016","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jiph.2015.05.007","article-title":"In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt","volume":"8","author":"Nageeb","year":"2015","journal-title":"J Infect Public Health"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918302024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:22:05Z","timestamp":1661649725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918302024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0924857918302024"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.07.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the in vitro activity of ceftazidime\/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}